The GFAP+Stat6+ cells significantly decreased in the AD groups (average 9.6 in CA1 and 10.2 in DG), compared to the Control (average 20.2 in CA1 and 22.4 in DG), and NS (average 20.8 of CA1 and 23.2 of DG) groups (p < 0.05). This evidence concerns the gene GFAP and Alzheimer disease.